Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in-Class Anti LLT1 Antibody

Jun 12, 2024

Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting...